Biotech Company And Former Executives Settle Charges Of Securities And Accounting Fraud
- Nov 13 2017
On November 2, 2017, the Securities and Exchange Commission (“SEC” or the “Commission”) announced (here) that it had charged Osiris Therapeutics, Inc. (“Osiris” or the “Company”), a Maryland-based biotech company, …